Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness

Vincente Pedraza, Jose A. Gomez-Capilla, Georgia Escaramis, Carolina Gomez, Pablo Torné, Jose M. Rivera, Angel Gil, Patricia Araque, Nicolas Olea, Xavier P. Estivill, M. Esther Fárez-Vidal

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

BACKGROUND: The development of reliable gene expression profiling technology is having an increasing impact on the understanding of breast cancer biology. METHODS: In this study, microarray analysis was performed to establish gene signatures for different breast cancer phenotypes, to determine differentially expressed gene sequences at different stages of the disease, and to identify sequences with biologic significance for tumor progression. Samples were taken from patients before their treatment. After microarray analysis, the expression level of 153 selected genes was studied by real-time quantitative polymerase chain reaction analysis. RESULTS: Several gene sequences were expressed differentially in tumor samples versus control samples and also were associated with different breast cancer phenotypes, estrogen receptor status, tumor histology, and grade of tumor differentiation. In lymph node-negative tumors were identified a set of genes related to tumor differentiation grade. CONCLUSIONS: Several differentially expressed gene sequences were identified at different stages of breast cancer.

Original languageEnglish
Pages (from-to)486-496
Number of pages11
JournalCancer
Volume116
Issue number2
DOIs
Publication statusPublished - 15 Jan 2010
Externally publishedYes

Fingerprint

Transcriptome
Breast Neoplasms
Phenotype
Genes
Neoplasms
Microarray Analysis
Gene Expression Profiling
Estrogen Receptors
Real-Time Polymerase Chain Reaction
Histology
Lymph Nodes
Technology

Keywords

  • Breast cancer
  • Gene expression signature
  • Microarrays
  • Real-time quantitative polymerase chain reaction
  • Tumor invasiveness

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Pedraza, V., Gomez-Capilla, J. A., Escaramis, G., Gomez, C., Torné, P., Rivera, J. M., ... Fárez-Vidal, M. E. (2010). Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness. Cancer, 116(2), 486-496. https://doi.org/10.1002/cncr.24805

Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness. / Pedraza, Vincente; Gomez-Capilla, Jose A.; Escaramis, Georgia; Gomez, Carolina; Torné, Pablo; Rivera, Jose M.; Gil, Angel; Araque, Patricia; Olea, Nicolas; Estivill, Xavier P.; Fárez-Vidal, M. Esther.

In: Cancer, Vol. 116, No. 2, 15.01.2010, p. 486-496.

Research output: Contribution to journalArticle

Pedraza, V, Gomez-Capilla, JA, Escaramis, G, Gomez, C, Torné, P, Rivera, JM, Gil, A, Araque, P, Olea, N, Estivill, XP & Fárez-Vidal, ME 2010, 'Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness', Cancer, vol. 116, no. 2, pp. 486-496. https://doi.org/10.1002/cncr.24805
Pedraza, Vincente ; Gomez-Capilla, Jose A. ; Escaramis, Georgia ; Gomez, Carolina ; Torné, Pablo ; Rivera, Jose M. ; Gil, Angel ; Araque, Patricia ; Olea, Nicolas ; Estivill, Xavier P. ; Fárez-Vidal, M. Esther. / Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness. In: Cancer. 2010 ; Vol. 116, No. 2. pp. 486-496.
@article{880221759cef47daaa567ea07084c055,
title = "Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness",
abstract = "BACKGROUND: The development of reliable gene expression profiling technology is having an increasing impact on the understanding of breast cancer biology. METHODS: In this study, microarray analysis was performed to establish gene signatures for different breast cancer phenotypes, to determine differentially expressed gene sequences at different stages of the disease, and to identify sequences with biologic significance for tumor progression. Samples were taken from patients before their treatment. After microarray analysis, the expression level of 153 selected genes was studied by real-time quantitative polymerase chain reaction analysis. RESULTS: Several gene sequences were expressed differentially in tumor samples versus control samples and also were associated with different breast cancer phenotypes, estrogen receptor status, tumor histology, and grade of tumor differentiation. In lymph node-negative tumors were identified a set of genes related to tumor differentiation grade. CONCLUSIONS: Several differentially expressed gene sequences were identified at different stages of breast cancer.",
keywords = "Breast cancer, Gene expression signature, Microarrays, Real-time quantitative polymerase chain reaction, Tumor invasiveness",
author = "Vincente Pedraza and Gomez-Capilla, {Jose A.} and Georgia Escaramis and Carolina Gomez and Pablo Torn{\'e} and Rivera, {Jose M.} and Angel Gil and Patricia Araque and Nicolas Olea and Estivill, {Xavier P.} and F{\'a}rez-Vidal, {M. Esther}",
year = "2010",
month = "1",
day = "15",
doi = "10.1002/cncr.24805",
language = "English",
volume = "116",
pages = "486--496",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness

AU - Pedraza, Vincente

AU - Gomez-Capilla, Jose A.

AU - Escaramis, Georgia

AU - Gomez, Carolina

AU - Torné, Pablo

AU - Rivera, Jose M.

AU - Gil, Angel

AU - Araque, Patricia

AU - Olea, Nicolas

AU - Estivill, Xavier P.

AU - Fárez-Vidal, M. Esther

PY - 2010/1/15

Y1 - 2010/1/15

N2 - BACKGROUND: The development of reliable gene expression profiling technology is having an increasing impact on the understanding of breast cancer biology. METHODS: In this study, microarray analysis was performed to establish gene signatures for different breast cancer phenotypes, to determine differentially expressed gene sequences at different stages of the disease, and to identify sequences with biologic significance for tumor progression. Samples were taken from patients before their treatment. After microarray analysis, the expression level of 153 selected genes was studied by real-time quantitative polymerase chain reaction analysis. RESULTS: Several gene sequences were expressed differentially in tumor samples versus control samples and also were associated with different breast cancer phenotypes, estrogen receptor status, tumor histology, and grade of tumor differentiation. In lymph node-negative tumors were identified a set of genes related to tumor differentiation grade. CONCLUSIONS: Several differentially expressed gene sequences were identified at different stages of breast cancer.

AB - BACKGROUND: The development of reliable gene expression profiling technology is having an increasing impact on the understanding of breast cancer biology. METHODS: In this study, microarray analysis was performed to establish gene signatures for different breast cancer phenotypes, to determine differentially expressed gene sequences at different stages of the disease, and to identify sequences with biologic significance for tumor progression. Samples were taken from patients before their treatment. After microarray analysis, the expression level of 153 selected genes was studied by real-time quantitative polymerase chain reaction analysis. RESULTS: Several gene sequences were expressed differentially in tumor samples versus control samples and also were associated with different breast cancer phenotypes, estrogen receptor status, tumor histology, and grade of tumor differentiation. In lymph node-negative tumors were identified a set of genes related to tumor differentiation grade. CONCLUSIONS: Several differentially expressed gene sequences were identified at different stages of breast cancer.

KW - Breast cancer

KW - Gene expression signature

KW - Microarrays

KW - Real-time quantitative polymerase chain reaction

KW - Tumor invasiveness

UR - http://www.scopus.com/inward/record.url?scp=75649101282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75649101282&partnerID=8YFLogxK

U2 - 10.1002/cncr.24805

DO - 10.1002/cncr.24805

M3 - Article

VL - 116

SP - 486

EP - 496

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -